메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology

BOSTON and ROLLE, Switzerland, Oct. 16, 2025 -- SOPHiA GENETICS (Nasdaq: SOPH), a leader in AI-driven precision medicine, today announced the launch of SOPHiA DDM™ Digital Twins, a breakthrough research technology that creates dynamic, virtual representations of individual patients to simulate potential outcomes and help oncologists make better treatment decisions. SOPHiA DDM™ Digital Twins uses each patient's unique clinical, biological, imaging, and genomic data to generate a computational replica of the patient and their individual disease. Oncologists can use the virtual
- 김갑성 기자
- 2025-10-16 16:01
Labuan IBFC Inc. and ASAS Forge Strategic Alliance to Advance Islamic Finance

KUALA LUMPUR, Malaysia, Oct. 16, 2025 -- Labuan IBFC Incorporated Sdn. Bhd. (Labuan IBFC Inc.) and the Association of Shariah Advisors in Islamic Finance Malaysia (ASAS) have formalised their strategic partnership through the signing of a Memorandum of Understanding (MoU). The event took place yesterday at Sasana Kijang, Kuala Lumpur, in conjunction with the Global Islamic Finance Forum (GIFF) 2025. This landmark MoU reflects both institutions' shared commitment to advancing the Islamic finance landscape by strengthening collaboration in key areas including business development
- 황정호 기자
- 2025-10-16 12:17
HARMONi-6 Phase III Study of Ivonescimab Accepted by The Lancet and Selected for ESMO 2025 LBA Presentation

HONG KONG, Oct. 16, 2025 -- Akeso Inc. (9926.HK) today announced that the groundbreaking results from the registrational Phase III AK112-306/HARMONi-6 study of ivonescimab have been accepted for publication in The Lancet. The study evaluated ivonescimab, a first-in-class PD-1/VEGF bispecific antibody, combined with chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small cell lung cancer (sq-NSCLC). The article of Lancet will be simultaneously published during the 2025 European Society for Medical Oncology (2025 ESMO) Congress. The HARM
- 김갑성 기자
- 2025-10-16 12:15
Forrester Announces Full Conference Agenda And Award Winners For B2B Summit APAC 2025

The event will empower B2B marketing leaders to master evolving buyer behaviors and embrace AI to drive business growth Salesforce, Google Cloud, and UiPath to be honored as recipients of Forrester's 2025 B2B Awards SINGAPORE, Oct. 16, 2025 -- Forrester (Nasdaq: FORR) today announced the full conference agenda for its B2B Summit APAC 2025, taking place on November 6 in Singapore. The B2B buying landscape is evolving dramatically with buyers choosing to make self-guided purchases from trusted providers. As a result, marketing leaders must think beyond traditional marketi
- 황정호 기자
- 2025-10-16 12:00
JMGO launches the O2S Ultra: the most advanced compact ultra-short throw tri-laser projector on the market

SHENZHEN, China, Oct. 16, 2025 -- JMGO unveils its latest innovation, the O2S Ultra, an intelligent ultra-short throw projector that redefines the home cinema experience. Capable of projecting a 100-inch image from just 16.8cm away from the wall, the O2S Ultra offers the shortest throw ratio on the market. It instantly transforms any living room into a true movie theater, combining exceptional image power, immersive Dynaudio sound, and refined design. Engineered to adapt to any space, the O2S Ultra projects a 100-inch image from just 16.8cm away from the wall. Easy to in
- 김장윤(JASON KIM) 기자
- 2025-10-16 12:00
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights

At ASHG, an early access customer from the London Health Sciences Center Research Institute demonstrated the power of the 5-base genome for accelerating resolution of rare disease cases Proprietary 5-base chemistry and novel DRAGEN algorithms enable dual-omic inquiry, providing researchers with new tool for precision medicine breakthroughs SAN DIEGO, Oct. 16, 2025 -- Illumina, Inc. (NASDAQ: ILMN) announced the release of its novel 5-base solution, enabling researchers to pursue broader biological questions with accuracy and ease. The 5-base solution marks a major advan
- 김갑성 기자
- 2025-10-16 11:43
ROSTI partners with IDC to bring innovative medical device design and manufacturing capabilities

SHANGHAI, Oct. 16, 2025 -- A report from Ringiertrade. MedTec China 2025, which took place at the Shanghai World Expo Exhibition & Convention Center (SWEECC) from September 24-26, served as the ideal platform to promote the latest innovations in the production of medical devices. At this exhibition, ROSTI Integrated Manufacturing Solutions (Suzhou) Co., Ltd. (ROSTI) provided visitors with interesting glimpse of its medical device design, assembly and production solutions aimed at the highly dynamic Asian markets. ROSTI, a pioneer injection molding and assembly for the medic
- 김갑성 기자
- 2025-10-16 11:30
Meey Group Advances International IPO Strategy

HANOI, Vietnam, Oct. 16, 2025 -- Meey Group, a pioneering force in Vietnam's real estate digital transformation, is accelerating its international IPO journey. In early October, the Group launched a series of strategic initiatives in the United States and Singapore, engaging with leading global financial and technology institutions. These moves underscore the firm's determination to integrate Vietnamese technology enterprises into the global capital markets and realize its vision of transparent and sustainable international listing. Connecting with Global Capital Markets On Octo
- 황정호 기자
- 2025-10-16 11:00
WLP Group Wins "e-Invoicing Champion of the Year (Singapore)" at Xero Asia Awards 2025

SINGAPORE, Oct. 16, 2025 -- WLP Group, a leading accounting and business consultancy firm founded in 2013, has been recognised as the e-Invoicing Champion of the Year (Singapore) at the prestigious Xero Asia Awards 2025 on 7 August 2025. This award celebrates Xero accounting partners in Singapore who have championed the adoption of e-Invoicing in their respective markets and created a positive change by educating clients on the benefits of e-Invoicing. Xero, the world's premier cloud accounting platform serving over 4 million subscribers, celebrates innovation and excellence i
- 황정호 기자
- 2025-10-16 11:00
Gene Solutions Brings Insights on Advances in MRD and Multi-Omics Technologies to the Singapore Society of Oncology Annual Scientific Meeting 2025

SINGAPORE, Oct. 15, 2025 -- What if cancer care could move from reactive to proactive? At the Singapore Society of Oncology Annual Scientific Meeting 2025 (SSO ASM 2025), Gene Solutions showcased how Molecular Residual Disease (MRD) and AI-powered multi-omics technologies are advancing precision oncology across Asia-Pacific, reinforcing Singapore's role as a hub for innovation and global collaboration. The symposium, "Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors," gathered leading oncologists and molecular biology experts to explore how ctDNA-MRD and mult
- 김갑성 기자
- 2025-10-16 10:30

이전

51 52 53 54 55 56 57 58 59 60

많이 본 기사

최근기사

2025-10-30_THU

2025-10-29_WED

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 30일 08시 20분